What happens if my oncologist and surgeon disagree about Prostate Cancer treatment

Prostate CancerMay 17, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

When Your Oncologist and Surgeon Disagree About Prostate Cancer Treatment

This is a genuinely important question, and you're right to take it seriously. Disagreements between specialists happen more often than you might think, especially in prostate cancer where treatment options have expanded significantly in recent years.

Why Disagreements Happen

According to the CancerPatientLab webinars on prostate cancer treatment, the field has undergone radical changes in the last few years. What was standard care even 5-10 years ago is no longer recommended today. This creates situations where:

  • Surgeons may emphasize removing the tumor tissue (which also provides material for testing)
  • Oncologists may recommend systemic treatments (drugs that work throughout the body) or different sequencing of treatments
  • Radiation oncologists have their own perspective on timing and approach

For example, in one case discussed in the webinars, a patient with oligometastatic prostate cancer (cancer in a few spots beyond the prostate) faced a choice between surgery plus radiation versus high-dose-rate brachytherapy plus radiation. The discussion revealed that brachytherapy had better research outcomes, but surgery offered the advantage of getting fresh tissue for functional testing to guide future treatment decisions.

The Key Framework: Your Goals Matter Most

According to the CancerPatientLab resources, the critical question isn't "who is right?" but rather "what are YOUR goals?" The webinars emphasize that treatment decisions should depend on:

  1. Are you seeking a cure now, or are you willing to accept a less aggressive approach that preserves options for future treatments?
  2. What is your disease burden? (How much cancer do you have, and where is it?)
  3. What matters most to you? Quality of life, survival length, avoiding certain side effects?

What You Should Do

Step 1: Understand the Specific Disagreement

Ask each doctor to clearly explain:

  • What treatment are they recommending?
  • Why do they recommend it?
  • What are the pros and cons compared to the other doctor's recommendation?
  • What does the current research show?

Step 2: Get a Third Opinion

This isn't about being difficult—it's about getting clarity. A third specialist (ideally a genitourinary medical oncologist experienced in prostate cancer) can help you understand:

  • Whether this is a genuine disagreement or just different emphasis
  • What the current evidence supports
  • How your specific situation (stage, Gleason score, biomarkers, age, health) influences the decision

The webinars emphasize that finding a "quarterback" for your care—someone well-versed in current research and connected with you—is crucial. This person should be willing to integrate information from multiple specialists.

Step 3: Ask These Specific Questions

To both doctors:

  1. "Based on my specific situation (stage, Gleason score, biomarkers), what does the current research show about outcomes with your recommended approach?"
  2. "How does your recommendation fit with the NCCN Guidelines for prostate cancer?" (The National Comprehensive Cancer Network publishes evidence-based guidelines that oncologists reference)
  3. "If I choose your approach and it doesn't work as hoped, what are my options for next steps?"
  4. "Are there any clinical trials that might be relevant to my situation?"

If they still disagree: 5. "Can you explain specifically where you disagree with [the other doctor's] recommendation and why?" 6. "What would change your mind about this recommendation?"

Step 4: Consider the Treatment Intensification Principle

According to the webinars, treatment intensification is now standard of care for newly diagnosed metastatic prostate cancer. This means:

  • Hormone therapy alone (like Lupron) is no longer standard
  • Combination approaches are preferred
  • The specific combination depends on your disease burden and other factors

If one doctor is recommending an older, single-agent approach and another is recommending combination therapy, the research supports the combination approach.

Red Flags to Watch For

Be cautious if a doctor:

  • Won't explain their reasoning in understandable terms
  • Dismisses the other doctor's opinion without engaging with it
  • Isn't aware of recent guideline changes
  • Won't discuss your specific goals and values
  • Seems unwilling to collaborate with other specialists

The Bottom Line

Disagreements between specialists are often resolvable once you understand:

  1. What each is optimizing for (immediate cure vs. long-term quality of life, etc.)
  2. What the current evidence actually shows
  3. How your specific situation influences the decision

According to the CancerPatientLab webinars, the most successful patients are those who actively engage in shared decision-making—understanding their options, asking tough questions, and choosing the path that aligns with their values and goals.


Questions to Ask Your Care Team:

  1. Can you walk me through the current NCCN Guidelines for my stage of prostate cancer?
  2. How do your recommendations align with recent clinical trial data?
  3. Would you be willing to discuss your approach with [the other specialist] to clarify the disagreement?
  4. What is your experience with the specific approach you're recommending?
  5. How will we monitor whether the treatment is working, and what are the backup plans?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: